| Breast Cancer |
1 |
1 |
| Breast |
0 |
0.69 |
| Cancer |
0 |
0.67 |
| Biologic Therapy |
0 |
0.6 |
| Estrogen Receptor-Positive Malignancy |
0 |
0.54 |
| Breast Conserving Surgery (BCS) |
0 |
0.51 |
| Breast Surgery |
0 |
0.49 |
| Genomic Medicine |
0 |
0.49 |
| Toxicology |
0 |
0.49 |
| Radiation Therapy |
0 |
0.99 |
| Surgery |
0 |
0.14 |
| Endocrine Therapy |
0 |
0.1 |
| Tumor |
0 |
0.08 |
| Lumpectomy |
0 |
0.98 |
| Receptors |
0 |
0.06 |
| Adherence |
0 |
0.02 |
| Biomarker |
0 |
0.02 |
| Biomedical Technology |
0 |
0.02 |
| Canada |
0 |
0.02 |
| Clinical Guidelines |
0 |
0.02 |
| Estrogen |
0 |
0.02 |
| Healthcare and Medical Technology |
0 |
0.02 |
| New York |
0 |
0.02 |
| Preventive Screening |
0 |
0.02 |
| Quality of Life |
0 |
0.02 |